Bisogni Maria Giuseppina, Attili Andrea, Battistoni Giuseppe, Belcari Nicola, Camarlinghi Niccolo', Cerello Piergiorgio, Coli Silvia, Del Guerra Alberto, Ferrari Alfredo, Ferrero Veronica, Fiorina Elisa, Giraudo Giuseppe, Kostara Eleftheria, Morrocchi Matteo, Pennazio Francesco, Peroni Cristiana, Piliero Maria Antonietta, Pirrone Giovanni, Rivetti Angelo, Rolo Manuel D, Rosso Valeria, Sala Paola, Sportelli Giancarlo, Wheadon Richard
University of Pisa, Department of Physics, Largo B. Pontecorvo 3, 56127 Pisa, Italy; Istituto Nazionale Fisica Nucleare INFN, Sezione di Pisa, Largo B. Pontecorvo 3, 56127 Pisa, Italy.
University of Torino, Department of Physics, Via Pietro Giuria 1, 10125, Torino, Italy; Istituto Nazionale Fisica Nucleare INFN, Sezione di Torino, Via Pietro Giuria 1, 10125, Torino, Italy.
J Med Imaging (Bellingham). 2017 Jan;4(1):011005. doi: 10.1117/1.JMI.4.1.011005. Epub 2016 Dec 2.
The quality assurance of particle therapy treatment is a fundamental issue that can be addressed by developing reliable monitoring techniques and indicators of the treatment plan correctness. Among the available imaging techniques, positron emission tomography (PET) has long been investigated and then clinically applied to proton and carbon beams. In 2013, the Innovative Solutions for Dosimetry in Hadrontherapy (INSIDE) collaboration proposed an innovative bimodal imaging concept that combines an in-beam PET scanner with a tracking system for charged particle imaging. This paper presents the general architecture of the INSIDE project but focuses on the in-beam PET scanner that has been designed to reconstruct the particles range with millimetric resolution within a fraction of the dose delivered in a treatment of head and neck tumors. The in-beam PET scanner has been recently installed at the Italian National Center of Oncologic Hadrontherapy (CNAO) in Pavia, Italy, and the commissioning phase has just started. The results of the first beam test with clinical proton beams on phantoms clearly show the capability of the in-beam PET to operate during the irradiation delivery and to reconstruct on-line the beam-induced activity map. The accuracy in the activity distal fall-off determination is millimetric for therapeutic doses.
粒子治疗的质量保证是一个根本性问题,可通过开发可靠的监测技术和治疗计划正确性指标来解决。在现有的成像技术中,正电子发射断层扫描(PET)长期以来一直被研究,随后被临床应用于质子束和碳离子束。2013年,强子治疗剂量学创新解决方案(INSIDE)合作项目提出了一种创新的双模态成像概念,即将束内PET扫描仪与用于带电粒子成像的跟踪系统相结合。本文介绍了INSIDE项目的总体架构,但重点关注束内PET扫描仪,该扫描仪旨在以毫米级分辨率重建粒子射程,其重建时间在头颈部肿瘤治疗中所输送剂量的一小部分内。束内PET扫描仪最近已安装在意大利帕维亚的意大利国家肿瘤强子治疗中心(CNAO),调试阶段刚刚开始。在体模上使用临床质子束进行的首次束流测试结果清楚地表明,束内PET能够在照射过程中运行,并在线重建束流诱导的活度图。对于治疗剂量,活度远端下降确定的精度为毫米级。